Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission, we hope you enjoy your experience

FBTAX Fidelity Advisor® Biotechnology A

  • Fund
  • FBTAX
  • Price as of: Sep 20, 2019
  • $25.62 + $0.16 + 0.63%

FBTAX - Profile

Vitals

  • YTD Return 8.6%
  • 3 Yr Annualized Return 4.3%
  • 5 Yr Annualized Return 3.1%
  • Net Assets $2.08 B
  • Holdings in Top 10 63.0%

52 WEEK LOW AND HIGH

$25.62
$21.69
$28.91

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.06%

SALES FEES

  • Front Load 5.75%
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 45.00%

TRADING FEES

  • Max Redemption Fee 0.75%

Min Investment

STANDARD (TAXABLE)

$0

IRA

$500

Fund Classification

PRIMARY CATEGORY

  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return 8.6%
  • 3 Yr Annualized Total Return 4.3%
  • 5 Yr Annualized Total Return 4.5%
  • Capital Gain Distribution Frequency Semi-Annually
  • Net Income Ratio -0.53%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency None

Fund Details

  • Legal Name Fidelity Advisor® Biotechnology Fund
  • Fund Family Name Fidelity Investments
  • Inception Date Dec 27, 2000
  • Shares Outstanding N/A
  • Share Class A
  • Currency USD
  • Domiciled Country United States
  • Manager Eirene Kontopoulos

Fund Description

The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments. The fund is non-diversified.

FBTAX - Performance

Return Ranking - Trailing

Period FBTAX Return Category Return Low Category Return High Rank in Category (%)
YTD 8.6% -0.7% 20.3% 76.58%
1 Yr -8.8% -27.9% 1.0% 43.12%
3 Yr 4.3%* -16.4% 14.0% 28.16%
5 Yr 3.1%* -11.2% 14.3% 20.83%
10 Yr 13.6%* -2.6% 14.0% 2.53%

* Annualized


Return Ranking - Calendar

Period FBTAX Return Category Return Low Category Return High Rank in Category (%)
2018 -6.0% -25.3% 21.5% 37.14%
2017 25.8% -10.8% 43.9% 14.56%
2016 -23.6% -31.6% 6.9% 87.00%
2015 5.8% -20.4% 13.8% 12.24%
2014 31.0% -5.8% 31.5% 2.17%

Total Return Ranking - Trailing

Period FBTAX Return Category Return Low Category Return High Rank in Category (%)
YTD 8.6% -0.7% 20.3% 76.58%
1 Yr -8.8% -27.9% 2.0% 52.29%
3 Yr 4.3%* -16.4% 15.7% 47.57%
5 Yr 4.5%* -11.2% 17.6% 42.71%
10 Yr 15.2%* -2.6% 17.1% 17.72%

* Annualized


Total Return Ranking - Calendar

Period FBTAX Return Category Return Low Category Return High Rank in Category (%)
2018 -6.0% -25.3% 22.2% 45.71%
2017 25.8% -10.8% 45.8% 16.50%
2016 -23.6% -24.2% 8.7% 95.00%
2015 11.4% -16.6% 15.2% 20.41%
2014 34.4% -5.8% 36.7% 8.70%

NAV & Total Return History

FBTAX - Holdings

Concentration Analysis

FBTAX Category Low Category High FBTAX % Rank
Net Assets 2.08 B 2.54 M 43.3 B 22.31%
Number of Holdings 75 30 390 57.85%
Net Assets in Top 10 1.37 B 604 K 17.9 B 16.53%
Weighting of Top 10 63.01% 23.0% 74.6% 4.96%

Top 10 Holdings

  1. AbbVie Inc 16.50%

  2. Vertex Pharmaceuticals Inc 9.59%

  3. Alexion Pharmaceuticals Inc 8.42%

  4. Amgen Inc 6.89%

  5. Celgene Corp 6.66%

  6. Gilead Sciences Inc 4.76%

  7. Neurocrine Biosciences Inc 2.93%

  8. FibroGen Inc 2.60%

  9. Ascendis Pharma A/S ADR 2.35%

  10. Sarepta Therapeutics Inc 2.31%


Asset Allocation

Weighting Return Low Return High FBTAX % Rank
Stocks
98.71% 78.78% 100.00% 27.27%
Cash
0.76% 0.00% 21.10% 73.55%
Preferred Stocks
0.53% 0.00% 2.47% 11.57%
Other
0.00% -4.27% 3.81% 50.41%
Convertible Bonds
0.00% 0.00% 0.18% 34.71%
Bonds
0.00% 0.00% 0.20% 35.54%

Stock Sector Breakdown

Weighting Return Low Return High FBTAX % Rank
Healthcare
97.62% 63.42% 99.67% 18.18%
Utilities
0.00% 0.00% 0.00% 28.10%
Technology
0.00% 0.00% 22.28% 77.69%
Real Estate
0.00% 0.00% 1.71% 31.40%
Industrials
0.00% 0.00% 3.11% 49.59%
Financial Services
0.00% 0.00% 6.30% 40.50%
Energy
0.00% 0.00% 0.31% 31.40%
Communication Services
0.00% 0.00% 2.11% 28.93%
Consumer Defense
0.00% 0.00% 1.58% 36.36%
Consumer Cyclical
0.00% 0.00% 5.27% 38.84%
Basic Materials
0.00% 0.00% 1.35% 55.37%

Stock Geographic Breakdown

Weighting Return Low Return High FBTAX % Rank
US
94.69% 60.36% 99.29% 8.26%
Non US
4.02% 0.00% 39.22% 89.26%

FBTAX - Expenses

Operational Fees

FBTAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.06% 0.10% 4.94% 64.22%
Management Fee 0.54% 0.09% 1.30% 4.96%
12b-1 Fee 0.25% 0.00% 1.00% 26.39%
Administrative Fee N/A 0.01% 0.40% N/A

Sales Fees

FBTAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load 5.75% 2.50% 5.75% 19.23%
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

FBTAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee 0.75% 0.75% 2.00% 73.17%

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

FBTAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 45.00% 0.00% 341.00% 59.82%

FBTAX - Distributions

Dividend Yield Analysis

FBTAX Category Low Category High FBTAX % Rank
Dividend Yield 0.00% 0.00% 1.21% 39.67%

Dividend Distribution Analysis

FBTAX Category Low Category High Category Mode
Dividend Distribution Frequency None Annually Annually Annually

Dividend Payout History


Net Income Ratio Analysis

FBTAX Category Low Category High FBTAX % Rank
Net Income Ratio -0.53% -2.24% 1.48% 68.81%

Capital Gain Distribution Analysis

FBTAX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Semi-Annually Annually Semi-Annually Annually

FBTAX - Managers

Eirene Kontopoulos

Manager

Start Date

Tenure

Tenure Rank

Jul 15, 2018

1.13

1.1%

Eirene Kontopoulos joined Fidelity Investments in 2007, she has worked as a research analyst and portfolio manager.


Tenure Analysis

Category Low

0.25

Category High

21.97

Category Average

9.56

Category Mode

19.35